Get the Stockscreener App
7.231
1.50%
-0.099
Alpha Tau Medical Ltd stock is traded at $7.231, with a volume of 181.79K.
It is down -1.50% in the last 24 hours and up +41.57% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
See More
Previous Close:
$7.33
Open:
$7.29
24h Volume:
181.79K
Relative Volume:
0.82
Market Cap:
$616.89M
Revenue:
-
Net Income/Loss:
$-29.64M
P/E Ratio:
-16.82
EPS:
-0.43
Net Cash Flow:
$-39.43M
1W Performance:
+11.76%
1M Performance:
+41.57%
6M Performance:
+135.95%
1Y Performance:
+71.90%
1-Day Range:
$7.07
$7.3691
1-Week Range:
$6.405
$7.59
52-Week Range:
$2.30
$7.89
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
7.235 | 624.99M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.46 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.11 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.87 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.40 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-23 | Initiated | Citigroup | Buy |
| Apr-24-23 | Initiated | H.C. Wainwright | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
Alpha Tau Medical Ltd Stock (DRTS) Latest News
S P Trends: Should I average down on WLKP stockMarket Movement Recap & Long-Term Safe Investment Ideas - baoquankhu1.vn
Alpha Tau Medical (NASDAQ:DRTS) Trading Up 7.2%Should You Buy? - MarketBeat
Quarterly Recap: What is Alpha Tau Medical Ltd Equity Warrants market positionWeekly Market Report & Consistent Profit Alerts - baoquankhu1.vn
Investment Review: Is Urban Outfitters Inc stock a good dividend stock2025 Buyback Activity & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Short Squeeze: Is Alpha Tau Medical Ltd stock overvalued or fairly priced2025 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026 - Seeking Alpha
Alpha Tau Medical (NASDAQ:DRTS) Cut to Strong Sell at Zacks Research - Defense World
Revenue Check: Does Investcorp AI Acquisition Corp Equity Warrant have strong EBITDA marginsJuly 2025 Action & Daily Profit Focused Screening - baoquankhu1.vn
Zacks Research Downgrades Alpha Tau Medical (NASDAQ:DRTS) to Strong Sell - MarketBeat
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
New Strong Sell Stocks for January 20th - The Globe and Mail
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 29.2% in December - MarketBeat
Analyst Calls: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly pricedEarnings Summary Report & Safe Entry Zone Tips - baoquankhu1.vn
Guidance Update: Is Alpha Tau Medical Ltd Equity Warrant in a consolidation phaseQuarterly Portfolio Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Alpha Tau Medical (NASDAQ:DRTS) Shares Down 6.2%Here's Why - MarketBeat
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
DRTS: Pivotal trials advance for Alpha DaRT, with strong data and U.S. commercialization plans in place - TradingView
DRTS: Pivotal trials and manufacturing scale-up position Alpha DaRT for major milestones in 2026 - TradingView — Track All Markets
DRTS: Transformative alpha-based cancer therapy nears pivotal data and regulatory milestones in 2024 - TradingView
Sentiment Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpWhat's Next? - MarketBeat
TG Therapeutics, Clover Health Investments, Nutrien And Other Big Stocks Moving Higher On Wednesday - Benzinga
Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week High – Here’s Why - Defense World
Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week HighHere's Why - MarketBeat
Aug Decliners: Why is Alpha Tau Medical Ltd stock going downQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Alpha Tau Medical stock rating reiterated at Buy by H.C. Wainwright - Investing.com UK
Alpha Tau Medical stock rating reiterated at Buy by H.C. Wainwright By Investing.com - Investing.com South Africa
Alpha Tau Medical Ltd.Ordinary Shares (NQ: DRTS - FinancialContent
Alpha Tau files first FDA PMA module for Alpha DaRT skin cancer therapy - MSN
Is Alpha Tau Medical Ltd. stock positioned well for digital economyJuly 2025 Update & Free Risk Controlled Daily Trade Plans - ulpravda.ru
How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stockQuarterly Portfolio Summary & Step-by-Step Swing Trade Plans - ulpravda.ru
Is Alpha Tau Medical Ltd. stock positioned for long term growthChart Signals & Precise Swing Trade Entry Alerts - Улправда
Value Recap: Will Alpha Tau Medical Ltd. stock attract ESG investors2025 Technical Patterns & Daily Growth Stock Investment Tips - ulpravda.ru
Will Alpha Tau Medical Ltd. stock deliver strong dividend growthWall Street Watch & Low Risk Entry Point Tips - ulpravda.ru
Is Alpha Tau Medical Ltd. stock cheap at current valuationPerformance Line Overview & what to check before ordering - ulpravda.ru
How risky is Alpha Tau Medical Ltd. Equity Warrant stock nowMarket Performance Summary & Consistent Profit Alerts - ulpravda.ru
Will Alpha Tau Medical Ltd. stock pay special dividendsJuly 2025 Levels & Safe Swing Trade Setups - ulpravda.ru
Will Alpha Tau Medical Ltd. stock deliver better than expected guidanceJuly 2025 Breakouts & Free Safe Entry Trade Signal Reports - Улправда
Will Alpha Tau Medical Ltd. stock benefit from infrastructure spending2025 Trading Recap & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Alpha Tau Medical Ltd. Equity Warrant stock supported by strong cash flowsMarket Sentiment Summary & Reliable Momentum Entry Alerts - Улправда
Will Alpha Tau Medical Ltd. Equity Warrant stock sustain high P E ratiosQuarterly Portfolio Report & High Win Rate Trade Tips - Улправда
Is Alpha Tau Medical Ltd. stock a buy in volatile marketsEarnings Performance Report & Fast Gain Swing Trade Alerts - ulpravda.ru
Is Alpha Tau Medical Ltd. stock supported by strong fundamentalsProfit Target & Safe Entry Trade Signal Reports - ulpravda.ru
Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Why Alpha Tau Medical Ltd. stock remains a top recommendation2025 Year in Review & Free Weekly Watchlist of Top Performers - Улправда
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's Why - MarketBeat
Dental EconomicsAlpha Tau Medical Ltd.Ordinary Shares (Nasdaq:DRTS) Price Chart - FinancialContent
Alpha Tau Medical to present corporate update at JP Morgan 2026 Healthcare Conference - MSN
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating By Investing.com - Investing.com South Africa
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):